←
R. Lor Randall2,316 posts
R. Lor Randall avatar

R. Lor Randall

@RLRandallMD

I am so fortunate to serve as Chair of the storied Department of Orthopaedic Surgery at the University of California, Davis. Tweets are my own.

◷ Joined June 2013▧ 435 Photos and videos
Dr. Kim E. Barrett avatar
⟳ R. Lor Randall retweeted
Dr. Kim E. Barrett@DrKimEBarrett·Nov 5

@UCDavisMed surgeon @RLRandallMD helped answer long-debated Q: how much healthy tissue must be removed with a tumor? In childhood sarcomas, margins small as 1 mm associated with low recurrence rates. "For a child, a few mm makes a lifelong difference". lnkd.in/p/gefksiMw

R. Lor Randall avatar
R. Lor Randall@RLRandallMD·Sep 1

Thanks @OncLive. @UCD_Cancer @UCDavisOrtho @UCDavisHealth @UCDavisMed @ctosociety @ASCOPost @OrthoToday @AAOS1 @aoa1887 @SarcomaAlliance @CureSarcoma

📈Three-dimensional cutting guides, robotic-guided surgery, near-infrared imaging, and AI-driven workflows may revolutionize sarcoma surgical management, according to @RLRandallMD, of @UCD_Cancer. Read on for more insights ➡️: onclive.com/view/novel-preci…

R. Lor Randall avatar
R. Lor Randall@RLRandallMD·Aug 24

Thx @OncLive @UCD_Cancer @UCDavisOrtho @UCDavisHealth @UCDAggieSquare @UCDavisMed @TGCTSupportorg @ctosociety @oncodaily @OncologyCompass @jbjs @ASCO @aoa1887 @OrthoToday

🗣️"The next phase [of research in TGCT] is not simply finding another drug that shrinks the tumor; it's determining which intervention provide the best long-term function and QOL for each individual patient," said @RLRandallMD of @UCD_Cancer on what’s next for TGCT treatments. Read more ➡️: onclive.com/view/systemic-th… #oncology #scmsm

R. Lor Randall avatar
R. Lor Randall@RLRandallMD·Jun 27

Thx @OncLive @UCDavisHealth @UCD_Cancer @UCDavisOrtho @AgentsMIB @ASCO @ctosociety @theNCI @AmericanCancer @CureSarcoma @OsteosarcomaNow @OSInstitute @AAOS1 @aoa1887 @ORSsociety @SarcomaAlliance @UofCalifornia @UCDavisMed @MBCNbuzz @NIH

@RLRandallMD of @UCD_Cancer reviews a longitudinal study in osteosarcoma showing a strong correlation between ctDNA status and clinical outcomes like EFS. #oncology #medtwitter #sarcoma hubs.li/Q04mQFL90

R. Lor Randall avatar
R. Lor Randall@RLRandallMD·May 25

On AI: "There can be no human autonomy in the face of technical autonomy." Jacque Ellul.Autonomy is a political or moral conception that brings together the ideas of freedom & control. To be autonomous is to be self-governing, independent, not ruled by an external law or force.LW

Post attachment
R. Lor Randall avatar
R. Lor Randall@RLRandallMD·May 23

Thx @OncLive @UCD_Cancer @UCDavisOrtho @UCDavisMed @ASCO @ctosociety @AACR @aoa1887 @AAOS1 @TGCTSupportorg @CureSarcoma @SarcomaAlliance

⚛️ “We are moving toward a model where tumor biology informs not only survival but how well patients function, and that is a meaningful evolution for our field,” said @RLRandallMD of @UCD_Cancer on the introduction of systemic therapies like pimicotinib in TGCT enables a tumor biology–informed approach to care. Read more here 📰: hubs.li/Q04hKmHc0 #oncology

Yuval Noah Harari avatar
⟳ R. Lor Randall retweeted
Yuval Noah Harari@harari_yuval·Apr 19

To prepare for the future, we must look beyond narrow technical skills and focus on social, emotional and physical skills that will allow us to be ready for whatever comes our way.

1:48
R. Lor Randall avatar
R. Lor Randall@RLRandallMD·Apr 7

Thx @OncLive @UCDavisOrtho @UCDavisHealth @UCD_Cancer @ASCO @aoa1887 @AAOS1 @AAHKS @SarcomaAlliance @CureSarcoma @Sarcoma_UK @AgentsMIB @ctosociety @MSTS_Ortho

⚛️ “This consensus provides much-needed initial clarity for the day-to-day management of PJIs in patients [with sarcoma] but also underscores how much work remains to elevate the evidence base,” said @RLRandallMD of @ucdavis on key takeaways from the BOOM consensus meeting on PJI management in orthopedic oncology. Read more here 📈: hubs.li/Q049NCYq0 #oncology

R. Lor Randall avatar
R. Lor Randall@RLRandallMD·Mar 27

Thx @OncLive. @UCD_Cancer @UCDavisOrtho @UCDavisHealth @AAHKS @MSTS_Ortho @ctosociety @AAOS1 @aoa1887

How should periprosthetic joint infections be managed in orthopedic oncology when high-level evidence is limited? In this clip, @RLRandallMD of @UCD_Cancer discusses the clinical impetus for the Birmingham Orthopedic Oncology Meeting (BOOM) initiative and the rationale for using a modified Delphi consensus approach in the setting of limited high-level evidence. ▶️ Watch this short and read the full Q&A for key takeaways from the BOOM report:🔗 hubs.li/Q048GXl20 #BoomConsensus #BOOM2026 #BJJ #orthopediconcology

1:05
R. Lor Randall avatar
R. Lor Randall@RLRandallMD·Mar 15

Thx @OncLive. @AAOS1 @ORSsociety @aoa1887 @ASCO @myESMO @SachinSarcoma @ItaSarcomaGroup @CureSarcoma @reininsarcoma @UCD_Cancer @UCDavisOrtho @UCDavisHealth @UofCalifornia

WATCH 📺: @RLRandallMD of @UCDavisHealth outlines key clinical and treatment variables associated with local recurrence risk in patients with nonmetastatic Ewing sarcoma treated with interval compression therapy. 📊 Delve into findings from this contemporary analysis by watching the video below! 👇 #sarcsm #oncology onclive.com/view/dr-randall-…

R. Lor Randall avatar
R. Lor Randall@RLRandallMD·Feb 27

Thx @OncLive @UCDavisOrtho @UCDavisHealth @UCDavisMedCntr @AAOS1 @aoa1887 @CureSarcoma @reininsarcoma @ASCO @Sarcoma_UK @RareCancerRF @TheCancerLetter

👀“The take-home message in this modern multi-modality therapy study is that future efforts should focus on identifying and intensifying treatment for the high-risk subsets," said @RLRandallMD of @UCD_Cancer on a local therapy modality analysis in nonmetastatic ewing sarcoma. Read more here ➡️: hubs.li/Q044LW4p0 #oncology

Prof. Carl Sagan avatar
⟳ R. Lor Randall retweeted
Prof. Carl Sagan@ProfCarlSagan·Jan 15

Carl Sagan warned us about it long ago, most people still ignore today.

2:28